[Preliminary exploration on effect of qilian decoction in intervention treatment of diabetes mellitus type 2 with insulin resistance and its influence on related inflammatory cytokines]

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Jul;24(7):593-5.
[Article in Chinese]

Abstract

Objective: To observe the synergistic effect of Qilian decoction (QLD) with corresponding hypoglycemic agents on insulin sensitivity in patients with diabetes mellitus type 2 and its influence on related inflammatory cytokines.

Methods: Sixty-two patients with diabetes mellitus type 2 were selected and randomly divided into two groups, they were treated with hypoglycemic agent in routine, and QLD was given orally, one dose taken in twice a day. Parameters as fasting blood glucose, insulin, peptide C, tumor necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP), interleukin 6 (IL-6) were measured before and after treatment, and insulin sensitive index (ISI) was also calculated.

Results: The level of fasting blood glucose lowered after treatment in both groups (P<0.01); levels of fasting insulin, peptide C, ISI, TNF-alpha, IL-6 and CRP significantly lowered after treatment (P<0.05 or P<0.01), and the effect was better than that in the control group (P<0.05 or P<0.01).

Conclusion: QLD could improve the insulin resistance and lower the levels of related inflammatory cytokines.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • C-Reactive Protein / metabolism
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drugs, Chinese Herbal / therapeutic use*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / blood
  • Insulin / therapeutic use
  • Insulin Resistance*
  • Interleukin-6 / blood*
  • Male
  • Middle Aged
  • Peptides / blood
  • Phytotherapy*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Drugs, Chinese Herbal
  • Hypoglycemic Agents
  • Insulin
  • Interleukin-6
  • Peptides
  • Tumor Necrosis Factor-alpha
  • polypeptide C
  • C-Reactive Protein